Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects
Recruiting
N/A
Interventional Study
Persistent Epithelial Defect
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 54 (estimated)
- Sponsor
- Universidad Autonoma de Nuevo Leon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Persistent epithelial defects (PED) are corneal ulcers that do not heal within the first two weeks of treatment with artificial tears or ocular lubricant ointment. It is believed that this condition is the result of the loss of certain substances normally present in the tears that aid in the healing process of the cornea. When the eye is healthy, these ulcers typically heal rapidly. However, when …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with persistent epithelial defect and at least one of the following diagnoses:
* Recurrent corneal epithelial defect.
* Neurotrophic corneal ulcer.
* Neurotrophic keratopathy secondary to any disease (i.e. diabetes mellitus, infection with herpes simplex virus …
Contacts